SCHEMBL5136397

SCHEMBL5136397

CC(C)(C)OC(=O)N1CCCN(C2CN(C(c3ccccc3)c3ccccc3)C2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
MEN1 O00255 3/20 0.46
MGLL Q99685 1/20 0.45
GPR119 Q8TDV5 1/20 0.45
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44
SKP2 Q13309 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
L3MBTL3 Q96JM7 1/20 0.43
ATM Q13315 1/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2D6 P10635 3/20 0.42
CYP2C9 P11712 3/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694333 0.95 KMT2A (0.50) KMT2AMEN1MGLLGPR119MAPT
SCHEMBL5136398 0.83 KMT2A (0.52) KMT2AMEN1MGLLMAPTKDM4E
SCHEMBL4734659 0.82 CYP2D6 (0.61) KMT2AMEN1MGLLMAPTKDM4E
SCHEMBL4013471 0.82 KMT2A (0.67) KMT2AMEN1MGLLGPR119MAPT
SCHEMBL16117974 0.80 KMT2A (0.46) KMT2AMEN1MGLLGPR119MAPT
SCHEMBL16822551 0.80 KMT2A (0.46) KMT2AMEN1MGLLGPR119ATM
SCHEMBL16117985 0.80 KMT2A (0.46) KMT2AMEN1MGLLGPR119ATM
SCHEMBL16822486 0.80 SLC6A9 (0.43) KMT2AMEN1MGLLGPR119ATM
SCHEMBL16822525 0.80 SLC6A9 (0.43) KMT2AMEN1MGLLGPR119ATM
SCHEMBL15000993 0.79 GPR119 (0.64) GPR119MAPTKDM4EL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899318-A1 NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AstraZeneca AB (SE) 2008-03-19 EP disclosed
WO-2006137791-A1 NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES ASTRAZENECA AB (SE) 2006-12-28 WO disclosed
US-6262046-B1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists PFIZER INC. 2001-07-17 US disclosed